The novel treatment of this peptide represents a significant breakthrough in the handling of type 2 diabetes. Different to existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide258607.blogs-service.com/73153328/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment